Ibio Inc Stock News

Toward the end of trading Tuesday, the Dow traded up 0.34% to 24215.39 while the NASDAQ fell 0.50% to 8,686.55. The S&P also rose, gaining 0.18% to 2,883.60. The U.S. is the...

Gainers Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) shares jumped 68.6% to $19.40 after the company presented positive preclinical and initial clinical data for SNDX-5613, its...

Midway through trading Tuesday, the Dow traded up 0.14% to 24167.41 while the NASDAQ fell 0.8% to 8662.89. The S&P also fell, dropping 0.02% to 2,877.81. The U.S. is the new...

Gainers Document Security Systems, Inc. (NYSE: DSS) shares rose 43.8% to $0.43 in pre-market trading after the company reported completion of required independent valuation,...

Gainers Amkor Technology (NASDAQ: AMKR) shares are trading higher after the company reported better-than-expected Q1 EPS and sales . The company also issued Q2 EPS guidance below...

- Company Expands Involvement in the Manufacturing USA® Network, Joining the National Institute for Innovation in Manufacturing Biopharmaceuticals - NEW YORK , April 27,.

Right from the get-go, the bull and bear case for iBio (NYSEAMERICAN:IBIO) is readily apparent. On one hand, IBIO stock skyrocketed this year due to the underlying company being one of the competitors

Under the MSAs, IDRI will support pre-clinical development and provide clinical trial oversight, while iBio will provide process development and manufacturing services to IDRI, as needed. Additionall

Inovio stock is up on hopes of solving the coronavirus puzzle. But INO stock has plenty of competition in that regard.

iBIO today announced that since the March 23rd launch of the iBIO COVID-19 PPE Response Fund, the Illinois life sciences community is making a significant impact in the fight against the coronavirus.

During the time of Ebola outbreak, there was one company whose stock price surged by 400%. The same company ended up paying $1.9 million in a false claim lawsuit, as investors accused the company of i